{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:24:41Z","timestamp":1793690681197,"version":"4.5.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41409-021-01553-x","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:03:35Z","timestamp":1642896215000},"page":"416-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Allogeneic hematopoietic cell transplantation in patients with myeloid\/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-3113","authenticated-orcid":false,"given":"Juan-Carlos","family":"Hern\u00e1ndez-Boluda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Zinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-4042","authenticated-orcid":false,"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Nikolousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabelle","family":"Chinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-9876","authenticated-orcid":false,"given":"Marie","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-5467","authenticated-orcid":false,"given":"Riccardo","family":"Saccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-3476","authenticated-orcid":false,"given":"John A.","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3680","authenticated-orcid":false,"given":"Panagiotis","family":"Tsirigotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Xicoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Daguindau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Lenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-4503","authenticated-orcid":false,"given":"Patrick","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Czerw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-091X","authenticated-orcid":false,"given":"Donal P.","family":"McLornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-8782","authenticated-orcid":false,"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,23]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood."},{"key":"1553_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ajh.21631","volume":"85","author":"MM Patnaik","year":"2010","unstructured":"Patnaik MM, Gangat N, Knudson RA, Keefe JG, Hanson CA, Pardanani A, et al. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. Am J Hematol. 2010;85:238\u201342.","journal-title":"Am J Hematol"},{"key":"1553_CR3","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1080\/10428194.2017.1397663","volume":"59","author":"P Strati","year":"2018","unstructured":"Strati P, Tang G, Duose DY, Mallampati S, Luthra R, Patel KP, et al. Myeloid\/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma. 2018;59:1672\u20136.","journal-title":"Leuk Lymphoma"},{"key":"1553_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1535-6108(04)00053-4","volume":"5","author":"S Roumiantsev","year":"2004","unstructured":"Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, Cross NC, et al. Distinct stem cell myeloproliferative\/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell. 2004;5:287\u201398.","journal-title":"Cancer Cell"},{"key":"1553_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","volume":"85","author":"RC Inhorn","year":"1995","unstructured":"Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood. 1995;85:1881\u20137.","journal-title":"Blood"},{"key":"1553_CR6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1182\/blood.V92.5.1735","volume":"92","author":"A Reiter","year":"1998","unstructured":"Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood. 1998;92:1735\u201342.","journal-title":"Blood."},{"key":"1553_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","volume":"41","author":"CC Jackson","year":"2010","unstructured":"Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol. 2010;41:461\u201376.","journal-title":"Hum Pathol"},{"key":"1553_CR8","first-page":"1628","volume":"9","author":"D Macdonald","year":"1995","unstructured":"Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia 1995;9:1628\u201330.","journal-title":"Leukemia"},{"key":"1553_CR9","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.3324\/haematol.2017.187302","volume":"103","author":"C Baer","year":"2018","unstructured":"Baer C, Muehlbacher V, Kern W, Haferlach C, Haferlach T. Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2. Haematologica. 2018;103:e348\u2013e50.","journal-title":"Haematologica."},{"key":"1553_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/leu.2015.136","volume":"30","author":"MS Khodadoust","year":"2016","unstructured":"Khodadoust MS, Luo B, Medeiros BC, Johnson RC, Ewalt MD, Schalkwyk AS, et al. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016;30:947\u201350.","journal-title":"Leukemia."},{"key":"1553_CR11","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1182\/bloodadvances.2020002308","volume":"4","author":"M Kasbekar","year":"2020","unstructured":"Kasbekar M, Nardi V, Dal Cin P, Brunner AM, Burke M, Chen YB, et al. Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia. Blood Adv. 2020;4:3136\u201340.","journal-title":"Blood Adv"},{"key":"1553_CR12","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdy173","volume":"29","author":"S Verstovsek","year":"2018","unstructured":"Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, et al. Treatment of the myeloid\/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol. 2018;29:1880\u20132.","journal-title":"Ann Oncol"},{"key":"1553_CR13","doi-asserted-by":"crossref","unstructured":"Verstovsek S, Vannucchi A, Rambaldi A, Gotlib J, Mead A, Hochhaus A, et al. Interim results from fight-203, a phase 2, open-label, multicenter study evaluating the efficacy and safety of pemigatinib (INCB054828) in patients with myeloid\/lymphoid neoplasms with rearrangement of fibroblast growth factor receptor 1 (FGFR1). Blood. 2018;132 :(abstract 690).","DOI":"10.1182\/blood-2018-99-110388"},{"key":"1553_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/pbc.23404","volume":"59","author":"M Dolan","year":"2012","unstructured":"Dolan M, Cioc A, Cross NC, Neglia JP, Tolar J. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatr Blood Cancer. 2012;59:194\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"1553_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41409-018-0287-1","volume":"54","author":"Y Konishi","year":"2019","unstructured":"Konishi Y, Kondo T, Nakao K, Asagoe K, Otsuka Y, Nishikori M, et al. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review. Bone Marrow Transpl. 2019;54:326\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"1553_CR16","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41409-019-0436-1","volume":"54","author":"S Katagiri","year":"2019","unstructured":"Katagiri S, Umezu T, Azuma K, Kobayashi C, Akahane D, Suguro T, et al. Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid\/lymphoid neoplasms with FGFR1 rearrangement. Bone Marrow Transpl. 2019;54:1148\u201350.","journal-title":"Bone Marrow Transpl"},{"key":"1553_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/bmt.2008.448","volume":"44","author":"W Townsend","year":"2009","unstructured":"Townsend W, Cross NC, Waghorn K, Somana K, Ramsay A, Thomson K, et al. Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder. Bone Marrow Transpl. 2009;44:197\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"1553_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1046\/j.1365-2141.2003.04269.x","volume":"121","author":"F Suzan","year":"2003","unstructured":"Suzan F, Guasch G, Terre C, Garcia I, Bastie JN, Maarek O, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol. 2003;121:312\u20134.","journal-title":"Br J Haematol"},{"key":"1553_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015;125:1333\u20138.","journal-title":"Blood."},{"key":"1553_CR20","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1182\/blood.V98.13.3778","volume":"98","author":"A Demiroglu","year":"2001","unstructured":"Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood. 2001;98:3778\u201383.","journal-title":"Blood."},{"key":"1553_CR21","doi-asserted-by":"crossref","unstructured":"Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, et al. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)\/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol. 2017;65:147\u201356.","DOI":"10.1016\/j.humpath.2017.05.008"},{"key":"1553_CR22","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1182\/bloodadvances.2020002727","volume":"4","author":"V Gupta","year":"2020","unstructured":"Gupta V, Kennedy JA, Capo-Chichi JM, Kim S, Hu ZH, Alyea EP, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase. Blood Adv. 2020;4:5562\u201373.","journal-title":"Blood Adv"}],"updated-by":[{"DOI":"10.1038\/s41409-022-01652-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01553-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:54:15Z","timestamp":1648821255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01553-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,23]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01553-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41409-022-01652-3","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,23]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41409-022-01652-3","URL":"https:\/\/doi.org\/10.1038\/s41409-022-01652-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing financial interests. This study was not economically funded. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. This retrospective study was approved by the Chronic Malignancies Working Party (CMWP) of EBMT. Informed consent for inclusion in the EBMT registry was obtained in all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}